Can a smartphone app and fitbit ease cancer treatment? new study says maybe.

NCT ID NCT03022032

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested whether a smartphone app (HOPE or SMART) paired with a Fitbit could help women with recurrent gynecologic cancer manage symptoms and improve quality of life during chemotherapy. 102 women participated, using the app to track symptoms and receive advice, while wearing a Fitbit to monitor activity. The main goal was to see if this approach was practical and acceptable to patients, not yet to prove it improves health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
smartphone app (HOPE app, SMART study app) and Fitbit wearable device
What this could lead to
If successful, this approach could provide a simple, home-based tool to help women with gynecologic cancer better manage symptoms and feel more in control during treatment.
What could go wrong
This was a small, early feasibility study (102 participants) focused on whether patients would use the app and Fitbit, not on whether it improves health outcomes. The results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dana Farber Cancer Institute

    Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.